Among numerous DNA copy number changes, losses of chromosome 13 are highly recurrent in plasmacytoma

Genes Chromosomes and Cancer

Volumn 25, Issue 2, 1999, Pages 104-107

  Aalto, Van ^a   Nordling, Stig ^b   Kivioja, Aarne H ^b   Karaharju, Erkki ^b   Elomaa, Inkeri ^b   Knuutila, Sakari ^a,b  

^a UNIVERSITY OF HELSINKI   (Finland)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CHROMOSOME 11Q; CHROMOSOME 14Q; CHROMOSOME 15; CHROMOSOME 19P; CHROMOSOME 1P; CHROMOSOME 1Q; CHROMOSOME 6P; CHROMOSOME 6Q; CHROMOSOME 7P; CHROMOSOME 8P; CHROMOSOME 8Q; CHROMOSOME 9Q; CHROMOSOME ABERRATION; CHROMOSOME LOSS; CLINICAL ARTICLE; DNA DETERMINATION; FEMALE; HUMAN; HUMAN TISSUE; MALE; PLASMACYTOMA; PRIORITY JOURNAL; RECURRENT CANCER; X CHROMOSOME;

ADULT; AGED; AGED, 80 AND OVER; ANEUPLOIDY; CHROMOSOMES, HUMAN, PAIR 13; FEMALE; GENE DOSAGE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PLASMACYTOMA;

EID: 0344731381     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2264(199906)25:2<104::AID-GCC5>3.0.CO;2-C     Document Type: Article

References (18)

1. Avet-Loiseau H, Andree-Ashiey LE, Moore II D, Mellerin MP, Feusner J, Bataille R, Pallavicini MG. 1997. Molecular cytogenetic abnormalities in multiple myeloma and plasma cell leukemia measured using comparative gcnomic hybridization. Genes Chromosomes Cancer 19:124-133.
2. Calasanz MJ, Cigudosa JC, Odero MD, Ferreira C, Ardanaz MT, Fraile A, Carrasco JL, Solé F, Cuesta B, Gullon A. 1997. Cytogenetic analysis of 280 patients with multiple myeloma and related disorders: primary breakpoints and clinical correlations. Genes Chromosomes Cancer 18:84-93.
3. Cigudosa JC, Rao PH, Calasanz MJ, Odero MD, Michaeli J, Jhanwar SC, Chaganti RSK. 1998. Characterization of nonrandom chromosomal gains and losses in multiple myeloma by comparative genomic hybridization. Blood 91:3007-3010.
4. Dao DD, Sawyer JR, Epstein J, Hoover RG, Barlogie B, Tricot G. 1994. Deletion of the retinoblastoma gene in multiple myeloma. Leukemia 8:1280-1284.
5. Durie B, Salmon S. 1975. A clinical staging system for multiple myeloma. Cancer 36:842-854.
6. El-Rifai W, Larramendy ML, Björkqvist A-M, Hemmer S, Knuutila S. 1997. Optimization of comparative genomic hybridization using fluorochrome conjugated to dCTP and dUTP nucleotides. Lab Invest 77:699-700.
7. Feinman R, Sawyer J, Hardin J, Tricot G. 1997. Cytogeneties and molecular genetics in multiple myeloma. Hematol Oncol Clin North Am 11:1-25.
8. Hallek M, Bergsagel PL, Anderson KC. 1998. Multiple myeloma: Increasing evidence for a multistep transformation process. Blood 91:3-21.
9. Juneau AL, Kaehler M, Christensen ER, Schad CR, Zinsmeister AR, Lust J, Hanson C, Dewald GW. 1998. Detection of RB1 deletions by fluorescence in situ hybridization in malignant hematologic disorders. Cancer Genet Cytogenet 103:117-123.
10. Kallioniemi O-P, Kallioniemi A, Piper J, Isola J, Waldman FM, Gray JW, Pinkel D. 1994. Optimizing comparative genomic hybridization for analysis of DNA sequence copy number changes in solid tumors. Genes Chromosomes Cancer 10:231-243.
11. Knuutila S, Björkqvist AM, Autio K, Tarkkanen M, Wolf M, Monni O, Szymanska J, Larramendy ML, Tapper J, Pere H, El-Rifai W, Hemmer S, Wasenius VM, Vidgren V, Zhu Y. 1998. DNA copy number amplifications in human neoplasms. Review of comparative genomic hybridization studies. Am J Pathol 152:1107-1123.
12. Larramendy ML, El-Rifai W, Knuutila S. 1998. Comparison of fluorescein isothiocyanate-and Texas red-conjugated nucleotides for direct labeling in comparative genomic hybridization. Cytometry 31:174-179.
13. Liu Y, Szekely L, Grandén D. Söderhäll S, Juliusson G, Gahrton G, Linder S, Einhorn S. 1993. Chronic lymphocytic leukemia cells with allelic deletions at 13q14 commonly have one intact RB1 gene: evidence for a role of an adjacent locus. Proc Natl Acad Sci USA 90:8697-8701.
14. Liu Y, Hermanson M, Grandén D, Merup M, Wu X, Heyman M, Rasool O, Juliusson G, Gahrton G, Detlofsson R, Nikiforova N, Buys C, Söderhäll S, Yankovsky N, Zabarovsky E, Einhorn S. 1995. 13q deletions in lymphoid malignancies. Blood 86:1911-1915.
15. Morris CM, Cochrane JM, Benjes SM, Crossen PE, Fitzgerald PH. 1991. Molecular definition of interstitial deletions of chromosome 13 in leukemic cells. Genes Chromosomes Cancer 3:455-460.
16. Pérez-Simón JA, García-Sanz R, Tabernero MD, Almeida J, González M, Fernández-Calvo J, Moro MJ, Hernández JM, San Miguel JE, Orfáo A. 1998. Prognostic value of numerical chromosome aberrations in multiple myeloma: a FISH analysis of 15 different chromosomes. Blood 91:3366-3371.
17. Sawyer JR, Waldron JA, Jagannath S, Barlogie B. 1995. Cytogenetic findings in 200 patients with multiple myeloma. Cancer Genet Cytogenet 82:41-49.
18. Tricot G, Barlogie B, Jagannath S, Bracy D, Mattox S, Vesole DH, Naucke S, Sawyer JR. 1995. Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalities. Blood 86:4250-4256.